Fig. 20From: Valuations using royalty data in the life sciences area—focused on anticancer and cardiovascular therapiesMain regression analysis of the cardiovascular dataset by statistical software for up-front payment (up-front fee + milestones): X-axis (real up-front payment) vs. Y-axis (predicted up-front payment)Back to article page